Newsletter | September 29, 2025

09.29.25 -- Building A Biotech Incubator And Accelerator

FEATURED PODCAST

Building A Biotech Incubator And Accelerator With Swiss Rockets Founder And CEO Vladimir Cmiljanovic, Ph.D.

On this episode, ex-handballer Vladimir Cmiljanovic, Ph.D., Founder and CEO at Swiss Rockets, talks about co-discovering bimiralisib with his sister Natasa Cmiljanovic, Ph.D. (and COO at Swiss Rockets), losing his company to a hostile takeover, buying the company back, and building out Swiss Rockets as an incubator with manufacturing capabilities and shared scientific expertise.

INDUSTRY INSIGHTS

Navigating The Complex World Of First In Human Oncology Trials

First-in-human oncology trials are critical touchpoints in the development of novel cancer therapies, requiring precise scientific execution and a deeply patient-centric approach.

Test Bed In Winston-Salem Boosts Emerging Field Of Regenerative Medicine

Discover a quiet lab in downtown Winston-Salem that is quietly fueling biotech innovation while offering startups free access to cutting-edge equipment and support.

Disclosure Management System: Build Or Buy?

Clinical trial disclosure regulations are tightening worldwide. In order to maintain compliance, sponsors must determine whether to build an internal disclosure management system or buy a solution.

Building An Analytics Culture In Clinical Development

Embracing fast, flexible clinical analytics can help you answer clinical questions and deliver insights into live data issues in real time rather than prior to submission.

Optimization-By-Design — A Critical Factor In Viral Vector Scale Up

Learn how leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using Design of Experiment (DoE), thereby reducing variability and risk.

What Treatment Options Do You Have For Me?

It’s the most important question from a patient-centric perspective. Examine the complexities surrounding patient access to treatment options, particularly in the context of clinical trials.